Related references
Note: Only part of the references are listed.Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro
Hui-ping Sun et al.
ACTA PHARMACOLOGICA SINICA (2016)
A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetes
Yousra M. El-Far et al.
NANOMEDICINE (2016)
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
Peter F. Surai
ANTIOXIDANTS (2015)
Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells
Li Fan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Silymarin Encapsulated Poly(D,L-lactic-co-glycolic acid) Nanoparticles: A Prospective Candidate for Prostate Cancer Therapy
K. S. Snima et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Silymarin Induces Insulin Resistance through an Increase of Phosphatase and Tensin Homolog in Wistar Rats
Kai-Chun Cheng et al.
PLOS ONE (2014)
Engineered Silybin Nanoparticles Educe Efficient Control in Experimental Diabetes
Suvadra Das et al.
PLOS ONE (2014)
Review of natural products with hepatoprotective effects
Eduardo Madrigal-Santillan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Hepatoprotective effect of silymarin
Nancy Vargas-Mendoza et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Immunosuppressive Effect of Silymarin on Mitogen-Activated Protein Kinase Signalling Pathway: the Impact on T Cell Proliferation and Cytokine Production
Marjan Gharagozloo et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy
Gagan Deep et al.
CURRENT CANCER DRUG TARGETS (2013)
Milk Thistle: A Future Potential Anti-Osteoporotic and Fracture Healing Agent
Nur Farhana Mohd Fozi et al.
CURRENT DRUG TARGETS (2013)
Nanomaterials in Cancer-Therapy Drug Delivery System
Gen Zhang et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2013)
Nanoparticle Delivery of Cancer Drugs
Andrew Z. Wang et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Investigation of Ehrlich ascites tumor cell death mechanisms induced by Synadenium umbellatum Pax.
Mariana Flavia da Mota et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
Cancer stem cells and drug resistance: the potential of nanomedicine
Serguei Vinogradov et al.
NANOMEDICINE (2012)
Angiopreventive Efficacy of Pure Flavonolignans from Milk Thistle Extract against Prostate Cancer: Targeting VEGF-VEGFR Signaling
Gagan Deep et al.
PLOS ONE (2012)
Antitumor activity and antioxidant role of a novel water-soluble carboxymethyl chitosan-based copolymer
Mohamed El-Far et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2011)
Curcumin Loaded Fibrinogen Nanoparticles for Cancer Drug Delivery
N. Sanoj Rejinold et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2011)
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Sleep aid use during and following breast cancer adjuvant chemotherapy
Tiffany A. Moore et al.
PSYCHO-ONCOLOGY (2011)
Solid lipid nanoparticles for ocular drug delivery
Ali Seyfoddin et al.
DRUG DELIVERY (2010)
Progress in nanotechnology for healthcare
V. Raffa et al.
MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES (2010)
Isosilybin A Induces Apoptosis in Human Prostate Cancer Cells via Targeting Akt, NF-κB, and Androgen Receptor Signaling
Gagan Deep et al.
MOLECULAR CARCINOGENESIS (2010)
Targeting mitochondria for cancer therapy
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Biochemical role of intravaginal sildenafil citrate as a novel antiabortive agent in unexplained recurrent spontaneous miscarriage: first clinical study of four case reports from Egypt
Mohamed El-Far et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
Marco Trappoliere et al.
JOURNAL OF HEPATOLOGY (2009)
Superoxide dismutases: a physiopharmacological update
A. Valdivia et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2009)
Serum levels of TNF-α and antioxidant enzymes and placental TNF-α expression in unexplained recurrent spontaneous miscarriage
M. El-Far et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2009)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy
Laura M. Vargas-Roig et al.
MOLECULAR ONCOLOGY (2008)
Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract
Zhiming Wen et al.
DRUG METABOLISM AND DISPOSITION (2008)
In vivo growth inhibitory and anti-angiogenic effects of synthetic novel dienone cyclopropoxy curcumin analogs on mouse Ehrlich ascites tumor
H. Chandru et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Chemopreventive effects of silymarin and silybinin on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in male ICR mice
Alpna Tyagi et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Effects and mechanisms of silibinin on human hepatoma cell lines
John J. Lah et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases:: clinical implications
Daehoon Park et al.
VIRCHOWS ARCHIV (2007)
Chemopreventive efficacy of silymarin in skin and prostate cancer
Gagan Deep et al.
INTEGRATIVE CANCER THERAPIES (2007)
Silymarin enhanced cytotoxic effect of anti-Fas agonistic antibody CH11 on A375-S2 cells
Lin-Hao Li et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2007)
Dexamethasone has pro-apoptotic effects on non-activated fresh peripheral blood mononuclear cells
PRR Totino et al.
CELL BIOLOGY INTERNATIONAL (2006)
Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin
G Deep et al.
ONCOGENE (2006)
The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats
YY Xiao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements
Barbara Malewicz et al.
CARCINOGENESIS (2006)
Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer
H Kaynar et al.
CANCER LETTERS (2005)
Milk thistle and prostate cancer:: Differential effects of pure flavonolignans from Silybum marianum on anti proliferative end points in human prostate carcinoma cells
PR Davis-Searles et al.
CANCER RESEARCH (2005)
Prostate cancer prevention by silibinin
RP Singh et al.
CURRENT CANCER DRUG TARGETS (2004)
Chronic ethanol ingestion and the risk of acute lung injury: a role for glutathione availability?
LAS Brown et al.
ALCOHOL (2004)
A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer
RP Singh et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2004)
Analysis of the active components of silymarin
F Kvasnicka et al.
JOURNAL OF CHROMATOGRAPHY A (2003)
Apoptogenic effects of black tea on Ehrlich's ascites carcinoma cell
A Bhattacharyya et al.
CARCINOGENESIS (2003)
Physiological responses of a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: III. Silymarin inhibits T-lymphocyte function at low doses but stimulates inflammatory processes at high doses
VJ Johnson et al.
PLANTA MEDICA (2003)
Pluronic® block copolymers for overcoming drug resistance in cancer
AV Kabanov et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Share Paper
